These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37758186)

  • 1. Canine cognitive decline and Alzheimer disease: clinical insights to solve a shared one-health problem.
    Ehrenzweig J; Hunter RP
    J Am Vet Med Assoc; 2023 Nov; 261(11):1597-1604. PubMed ID: 37758186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-health approach to canine cognitive decline: Dogs Overcoming Geriatric Memory and Aging Initiative for early detection of cognitive decline.
    Hunter RP; Ehrenzweig J; Hainsworth A; Crawford A; Dagan A; Sage J; Araujo J
    Am J Vet Res; 2023 Nov; 84(11):. PubMed ID: 37739391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canine Cognitive Dysfunction: Pathophysiology, Diagnosis, and Treatment.
    Dewey CW; Davies ES; Xie H; Wakshlag JJ
    Vet Clin North Am Small Anim Pract; 2019 May; 49(3):477-499. PubMed ID: 30846383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous skin-derived neural precursor cell therapy reverses canine Alzheimer dementia-like syndrome in a proof of concept veterinary trial.
    Valenzuela M; Duncan T; Abey A; Johnson A; Boulamatsis C; Dalton MA; Jacobson E; Brunel L; Child G; Simpson D; Buckland M; Lowe A; Siette J; Westbrook F; McGreevy P
    Stem Cell Res Ther; 2022 Jun; 13(1):261. PubMed ID: 35715872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcranial photobiomodulation (laser) therapy for cognitive impairment: A review of molecular mechanisms and potential application to canine cognitive dysfunction (CCD).
    Dewey CW; Brunke MW; Sakovitch K
    Open Vet J; 2022; 12(2):256-263. PubMed ID: 35603072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dogs with Cognitive Dysfunction as a Spontaneous Model for Early Alzheimer's Disease: A Translational Study of Neuropathological and Inflammatory Markers.
    Schütt T; Helboe L; Pedersen LØ; Waldemar G; Berendt M; Pedersen JT
    J Alzheimers Dis; 2016 Mar; 52(2):433-49. PubMed ID: 27003213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of tau hyperphosphorylation in canine dementia resembles early Alzheimer's disease and other tauopathies.
    Abey A; Davies D; Goldsbury C; Buckland M; Valenzuela M; Duncan T
    Brain Pathol; 2021 Jan; 31(1):144-162. PubMed ID: 32810333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electroencephalographic signatures of dogs with presumptive diagnosis of canine cognitive dysfunction.
    Mondino A; Gutiérrez M; González C; Mateos D; Torterolo P; Olby N; Delucchi L
    Res Vet Sci; 2022 Dec; 150():36-43. PubMed ID: 35803005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between physical activity and cognitive dysfunction in older companion dogs: results from the Dog Aging Project.
    Bray EE; Raichlen DA; Forsyth KK; Promislow DEL; Alexander GE; MacLean EL;
    Geroscience; 2023 Apr; 45(2):645-661. PubMed ID: 36129565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncloaking cognitive decline: the emergence of canine cognitive dysfunction in veterinary medicine and its implications for understanding Alzheimer's disease.
    Oates SM
    Vet Herit; 2014 Nov; 37(2):47-51. PubMed ID: 25799612
    [No Abstract]   [Full Text] [Related]  

  • 11. Canine cognitive dysfunction patients have reduced total hippocampal volume compared with aging control dogs: A comparative magnetic resonance imaging study.
    Dewey CW; Rishniw M; Johnson PJ; Platt S; Robinson K; Sackman J; O'Donnell M
    Open Vet J; 2021 Jan; 10(4):438-442. PubMed ID: 33614439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral administration of an integrative supplement (CogniCaps
    Dewey CW; Rishniw M; Sakovitch K; Hollenbeck J
    Open Vet J; 2023 Feb; 13(2):188-192. PubMed ID: 37073246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An observational study with long-term follow-up of canine cognitive dysfunction: clinical characteristics, survival, and risk factors.
    Fast R; Schütt T; Toft N; Møller A; Berendt M
    J Vet Intern Med; 2013; 27(4):822-9. PubMed ID: 23701137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dogs with cognitive dysfunction syndrome: a natural model of Alzheimer's disease.
    Bosch MN; Pugliese M; Gimeno-Bayón J; Rodríguez MJ; Mahy N
    Curr Alzheimer Res; 2012 Mar; 9(3):298-314. PubMed ID: 21875411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the role of psychiatrists in the diagnosis and management of mild cognitive impairment and mild Alzheimer's disease dementia: a cross-sectional survey.
    Gopalakrishna G; Brunton S; Pruzin J; Alford S; Hamersky C; Sabharwal A
    BMC Psychiatry; 2023 Oct; 23(1):716. PubMed ID: 37794326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive Function, Progression of Age-related Behavioral Changes, Biomarkers, and Survival in Dogs More Than 8 Years Old.
    Schütt T; Toft N; Berendt M
    J Vet Intern Med; 2015; 29(6):1569-77. PubMed ID: 26463980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcranial photobiomodulation therapy improves cognitive test scores in dogs with presumptive canine cognitive dysfunction: A case series of five dogs.
    Dewey CW; Rishniw M; Brunke MW; Gerardi J; Sakovitch K
    Open Vet J; 2024 May; 14(5):1167-1171. PubMed ID: 38938435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma β-amyloid peptides in canine aging and cognitive dysfunction as a model of Alzheimer's disease.
    González-Martínez Á; Rosado B; Pesini P; Suárez ML; Santamarina G; García-Belenguer S; Villegas A; Monleón I; Sarasa M
    Exp Gerontol; 2011 Jul; 46(7):590-6. PubMed ID: 21377518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomic identification of brain proteins in the canine model of human aging following a long-term treatment with antioxidants and a program of behavioral enrichment: relevance to Alzheimer's disease.
    Opii WO; Joshi G; Head E; Milgram NW; Muggenburg BA; Klein JB; Pierce WM; Cotman CW; Butterfield DA
    Neurobiol Aging; 2008 Jan; 29(1):51-70. PubMed ID: 17055614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study.
    Millar PR; Gordon BA; Luckett PH; Benzinger TLS; Cruchaga C; Fagan AM; Hassenstab JJ; Perrin RJ; Schindler SE; Allegri RF; Day GS; Farlow MR; Mori H; Nübling G; ; Bateman RJ; Morris JC; Ances BM
    Elife; 2023 Jan; 12():. PubMed ID: 36607335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.